{"id":793511,"date":"2024-12-09T16:09:12","date_gmt":"2024-12-09T21:09:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/"},"modified":"2024-12-09T16:09:12","modified_gmt":"2024-12-09T21:09:12","slug":"oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/","title":{"rendered":"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings"},"content":{"rendered":"

\nJanuary 13-16, 2025, San Francisco, CA
\n<\/h2>\n
\n

IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) — Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend \u201cJ.P. Morgan Week,\u201d coinciding with the 43\u02b3\u1d48\u00a0Annual J.P. Morgan Healthcare Conference in San Francisco, from January 13-16, 2025. During this period, Oncocyte will host one-on-one meetings with interested investors.<\/p>\n

Investors wishing to schedule a meeting are encouraged to contact Julie Silber at PCG Advisory via email at jsilber@pcgadvisory.com<\/a>.<\/p>\n

\n Event:<\/strong> \u201cJ.P. Morgan Week\u201d
Dates:<\/strong> January 13-16, 2025
Location:<\/strong> San Francisco, CA, USA<\/p>\n

\n About\u00a0Oncocyte<\/strong>
\n
Oncocyte\u00a0is a diagnostics technology company. The Company\u2019s tests are designed to help provide clarity and confidence to physicians and their patients. VitaGraft\u2122 is a clinical blood-based solid organ transplantation monitoring test. GraftAssure\u2122 is a research use only (RUO) blood-based solid organ transplantation monitoring test. DetermaIO\u2122 is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaCNI\u2122 is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. For more information about\u00a0Oncocyte, please visit\u00a0https:\/\/oncocyte.com\/<\/a>. For more information about our products, please visit the following web pages:<\/p>\n

\n VitaGraft Kidney\u2122\u00a0\u2013\u00a0<\/strong>
\n
\n https:\/\/oncocyte.com\/vitagraft-kidney\/<\/strong>
\n <\/a>
\n
\n
\n <\/a>
\n VitaGraft Liver\u2122\u00a0\u2013\u00a0<\/strong>
\n
\n https:\/\/oncocyte.com\/vitagraft-liver\/<\/strong>
\n <\/a>
\n
\n GraftAssure\u2122\u00a0\u2013\u00a0<\/strong>
\n
\n https:\/\/oncocyte.com\/graftassure\/<\/strong>
\n <\/a>
\n
\n
\n <\/a>
\n DetermaIO\u2122\u00a0\u2013\u00a0<\/strong>
\n
\n https:\/\/oncocyte.com\/determa-io\/<\/strong>
\n <\/a>
\n
\n
\n <\/a>
\n DetermaCNI\u2122\u00a0\u2013\u00a0<\/strong>
\n
\n https:\/\/oncocyte.com\/determa-cni\/<\/strong>
\n <\/a>\n <\/p>\n

\n VitaGraft\u2122, GraftAssure\u2122, DetermaIO\u2122, and DetermaCNI\u2122 are trademarks of\u00a0Oncocyte Corporation.<\/strong>\n <\/p>\n

\n CONTACT:<\/strong>
\n
Jeff Ramson
PCG Advisory
(646) 863-6893
jramson@pcgadvisory.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

January 13-16, 2025, San Francisco, CA IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) — Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend \u201cJ.P. Morgan Week,\u201d coinciding with the 43\u02b3\u1d48\u00a0Annual J.P. Morgan Healthcare Conference in San Francisco, from January 13-16, 2025. During this period, Oncocyte will host one-on-one meetings with interested investors. Investors wishing to schedule a meeting are encouraged to contact Julie Silber at PCG Advisory via email at jsilber@pcgadvisory.com. Event: \u201cJ.P. Morgan Week\u201dDates: January 13-16, 2025Location: San Francisco, CA, USA About\u00a0Oncocyte Oncocyte\u00a0is a diagnostics technology company. The Company\u2019s tests are designed to help provide clarity and confidence to physicians and their patients. … <\/p>\n

Continue reading “Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-793511","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"January 13-16, 2025, San Francisco, CA IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) — Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend \u201cJ.P. Morgan Week,\u201d coinciding with the 43\u02b3\u1d48\u00a0Annual J.P. Morgan Healthcare Conference in San Francisco, from January 13-16, 2025. During this period, Oncocyte will host one-on-one meetings with interested investors. Investors wishing to schedule a meeting are encouraged to contact Julie Silber at PCG Advisory via email at jsilber@pcgadvisory.com. Event: \u201cJ.P. Morgan Week\u201dDates: January 13-16, 2025Location: San Francisco, CA, USA About\u00a0Oncocyte Oncocyte\u00a0is a diagnostics technology company. The Company\u2019s tests are designed to help provide clarity and confidence to physicians and their patients. … Continue reading "Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-09T21:09:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings\",\"datePublished\":\"2024-12-09T21:09:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/\",\"name\":\"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==\",\"datePublished\":\"2024-12-09T21:09:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/","og_locale":"en_US","og_type":"article","og_title":"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings - Market Newsdesk","og_description":"January 13-16, 2025, San Francisco, CA IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) — Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend \u201cJ.P. Morgan Week,\u201d coinciding with the 43\u02b3\u1d48\u00a0Annual J.P. Morgan Healthcare Conference in San Francisco, from January 13-16, 2025. During this period, Oncocyte will host one-on-one meetings with interested investors. Investors wishing to schedule a meeting are encouraged to contact Julie Silber at PCG Advisory via email at jsilber@pcgadvisory.com. Event: \u201cJ.P. Morgan Week\u201dDates: January 13-16, 2025Location: San Francisco, CA, USA About\u00a0Oncocyte Oncocyte\u00a0is a diagnostics technology company. The Company\u2019s tests are designed to help provide clarity and confidence to physicians and their patients. … Continue reading \"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-09T21:09:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings","datePublished":"2024-12-09T21:09:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/","name":"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==","datePublished":"2024-12-09T21:09:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNjMzNiM2NjI5MjA3IzUwMDExOTgzOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncocyte-to-participate-in-j-p-morgan-week-and-host-investor-meetings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oncocyte to Participate in \u201cJ.P. Morgan Week\u201d and Host Investor Meetings"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/793511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=793511"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/793511\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=793511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=793511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=793511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}